Shyam Bhupalam
Nephrology · Duluth, MNNPI 1124078332
Payments from drug & device makers
What this record shows
Vantive US Healthcare LLC accounts for 79.0% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $1,078, 4.7 times the $231 reported in 2019.
Across 25 payments — averaging $54.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vantive US Healthcare LLC$1K
- Akebia Therapeutics Inc$66
- Amgen$54
- Shire North American Group Inc$43
- AstraZeneca$38
- Nxstage Medical, Inc.$28
- plus $57 from 3 others
What the payments were for
- Travel & lodging$77056%
- Food & beverage$59344%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vantive US Healthcare LLC | 8 | $1,078 |
| Akebia Therapeutics Inc | 5 | $66 |
| Amgen | 3 | $54 |
| Shire North American Group Inc | 2 | $43 |
| AstraZeneca | 3 | $38 |
| Nxstage Medical, Inc. | 1 | $28 |
| Amicus Therapeutics, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $19 |
| Fresenius USA Marketing, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - Acute$895
How this compares
$1,364 in reported general payments places this provider in the 80th percentile of 208 nephrology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 22 | $18,511 |
| Sevelamer Carbonate | 77 | $15,623 |
| Calcium Acetate | 22 | $1,496 |
| Calcitriol | 36 | $937 |
| Lisinopril | 45 | $623 |
| Amlodipine Besylate | 78 | $532 |
| Furosemide | 71 | $469 |
| Torsemide | 24 | $421 |
| Hydralazine Hcl | 25 | $307 |
| Losartan Potassium | 28 | $300 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $287 |
| Metoprolol Succinate | 15 | $247 |
| Minoxidil | 12 | $238 |
| Clonidine Hcl | 29 | $232 |
| Potassium Citrate ErPotassium Citrate | 11 | $218 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaLokelma | $38 | $18,51122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 208 nephrology providers in Minnesota.
Other nephrology in Duluth
- Prince SinghDuluth$26K
- Elyas SafarDuluth$18K
- Apurv KhannaDuluth$3K
- Sreedhar DevathiDuluth$1K
- Danijela MataicDuluth$555
- Neera DahlRochester$102K
- Fernando FervenzaRochester$102K
- Kirsten JohansenMinneapolis$101K
- Jeffrey KohenMinneapolis$56K
- James WetmoreMinneapolis$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.